Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Asset Utilization Ratio (2016 - 2025)

IGC Pharma (IGC) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.13 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 10.81% to 0.13 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.13, a 10.81% increase, with the full-year FY2025 number at 0.14, up 37.22% from a year prior.
  • Asset Utilization Ratio was 0.13 for Q3 2025 at IGC Pharma, down from 0.16 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.16 in Q2 2025 to a low of 0.01 in Q3 2021.
  • A 5-year average of 0.07 and a median of 0.08 in 2023 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: crashed 89.41% in 2021, then soared 277.81% in 2022.
  • IGC Pharma's Asset Utilization Ratio stood at 0.01 in 2021, then skyrocketed by 277.81% to 0.04 in 2022, then surged by 112.06% to 0.09 in 2023, then surged by 45.12% to 0.13 in 2024, then fell by 1.61% to 0.13 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Asset Utilization Ratio are 0.13 (Q3 2025), 0.16 (Q2 2025), and 0.14 (Q1 2025).